Chemtura Misses Squarely - Analyst Blog
01 Mars 2013 - 9:50AM
Zacks
Specialty chemical company
Chemtura Corporation’s (CHMT) fourth-quarter 2012
profit from continuing operation rose 13% year over year to $27
million or 27 cents a share from $24 million or 24 cents a share a
year ago, aided by higher sales. Adjusted earnings (excluding
one-time items) of 15 cents per share missed the Zacks Consensus
Estimate of 32 cents.
For the full year, profit (from
continuing operation) jumped 43% year over year to $134 million or
$1.35 per share. Adjusted earnings of $1.16 per share missed the
Zacks Consensus Estimate of $1.46.
Revenues went up 8% year over
year to $622 million in the fourth quarter, but missed the Zacks
Consensus Estimate of $681 million. The results were driven by
healthy growth across the company’s AgroSolutions and Industrial
Engineered Products divisions. However, Chemtura saw weak demand
for its organometallic tin products used in automotive and glass
applications.
For the full year, sales edged up
1% year over year to $2,629 million, falling behind the Zacks
Consensus Estimate of $2,974 million.
Revenues from the Industrial
Performance Products segment inched up 1% year over year to $214
million in the reported quarter. Higher sales volumes were offset
by a decline in selling prices. The company saw weak margin for the
petroleum additive products.
Industrial Engineered Products
division’s sales jumped 14% to $221 million on higher volumes and
pricing. Higher demand for oilfield, electronic and insulation foam
products masked weakness across building, construction, automotive
applications and organometallic products.
Revenues from the Consumer
Products unit rose 2% to $89 million on higher sales
volume.
Chemtura AgroSolutions segment’s
sales jumped 14% to $98 million on higher sales volume and pricing.
Sales benefited from drier climate and gains in resale and seed
treatment products.
Chemtura exited 2012 with cash
and cash equivalents of $363 million, more-than-double year over
year. Long-term debt jumped 16% year over year to $871 million.
Operating cash flow surged 20% year over year to $218 million in
2012.
Moving ahead, Chemtura sees
improved demand environment across the industrial markets in
serves. While the company envisions some challenges in
first-quarter 2013, it expects demand to recover as the year
progresses, aided by Asia-Pacific. The company will remain focused
on margin improvement and bringing new products to its customers.
Chemtura makes and distributes
specialty chemical solutions and consumer products globally. Its
broad range of offerings includes recreational water purification
products, petroleum additives, seed treatments, pesticides, bromine
and bromine-based products and hot cast elastomers. The company
serves a host of industries including agriculture, automotive,
building and construction, electronics, packaging, plastics and
transportation.
Chemtura currently carries a
Zacks Rank #3 (Hold).
Other companies in the specialty chemicals industry with a
favorable Zacks Rank are Novozymes A/S (NVZMY),
Penford Corporation (PENX) and Quaker
Chemical Corporation (KWR). All of them hold a Zacks Rank
#1 (Strong Buy).
CHEMTURA CORP (CHMT): Free Stock Analysis Report
QUAKER CHEMICAL (KWR): Free Stock Analysis Report
NOVOZYMES A/S (NVZMY): Get Free Report
PENFORD CORP (PENX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Novenesis AS (PK) (USOTC:NVZMY)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Novenesis AS (PK) (USOTC:NVZMY)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025